新标准引导下的分化型甲状腺癌的临床诊疗现状

Current status of diagnosis and treatment in differentiated thyroid carcinoma under the guidance of new standards

  • 摘要: 分化型甲状腺癌是最常见的内分泌系统肿瘤,可以分为乳头状甲状腺癌和滤泡状甲状腺癌。目前临床诊断以超声检查为主,治疗以手术为主,辅以促甲状腺激素抑制治疗和131I治疗。近年来,分化型甲状腺癌发病率逐年升高,并居各甲状腺癌之首,同期不断有新的研究发现并提出新的诊治观点。为此,笔者拟对分化型甲状腺癌的诊疗现状及最新进展进行综述。

     

    Abstract: Differentiated thyroid carcinoma(DTC), which can be divided into papillary thyroid carcinoma and follicular thyroid carcinoma, is the most common malignant tumor of the endocrine system. Ultrasound of DTC features important clinical value. The treatment of DTC includes surgery, thyroid stimulating hormone-suppression, and 131I radiotherapy in vivo. DTC presents the highest incidence of thyroid cancer, and the value has increased annually in recent years. At the same time, new research have constantly put forward new viewpoints in diagnosis and treatment of DTC. The diagnosis and treatment of differentiated thyroid carcinoma were investigated and reviewed in this article.

     

/

返回文章
返回